Line 76: | Line 76: | ||
{{#tag:html| | {{#tag:html| | ||
<h1 id="Results">Results</h1> | <h1 id="Results">Results</h1> | ||
− | In a first step, we wanted to validate our AP. Therefore, we added theophylline with a concentration of 100 µM to our inoculated culture and performed two rounds of PREDCEL. Afterwards, we determined the phage titers by <a href="https://2017.igem.org/Team:Heidelberg/Experiments">plaque assays</a>. Our theophylline treated culture displayed approximately two times higher phage titers than the non-treated control culture. | + | In a first step, we wanted to validate our AP. Therefore, we added theophylline with a concentration of 100 µM to our inoculated culture and performed two rounds of PREDCEL. Afterwards, we determined the phage titers by <a href="https://2017.igem.org/Team:Heidelberg/Experiments">plaque assays</a>. Our theophylline treated culture displayed approximately two times higher phage titers than the non-treated control culture indicating that our riboswitch selectively binds theophylline and is thereby activated. |
Using the same experimental conditions, but replacing the theophylline treatment by a 300 µM caffeine treatment, we verified the functionality of CYP1A2 and thus of our SP. If caffeine is added to the culture, CYP1A2 catalyzes the reaction from caffeine to theophylline. The resulting increase of the theophylline concentration further activates the riboswitch on the AP and phage propagation is stimulated (Fig. 6). | Using the same experimental conditions, but replacing the theophylline treatment by a 300 µM caffeine treatment, we verified the functionality of CYP1A2 and thus of our SP. If caffeine is added to the culture, CYP1A2 catalyzes the reaction from caffeine to theophylline. The resulting increase of the theophylline concentration further activates the riboswitch on the AP and phage propagation is stimulated (Fig. 6). | ||
For the evolution of proteins via PREDCEL the addition of a Mutagenesis Plasmid (MP) is essential. For our cytochrome engineering approach we have chosen MP4, which induces a medium mutation rate <x-ref>badran2015development</x-ref>. After six iterations of our optimized PREDCEL workflow, we performed plaque assays and sequenced single plaques. The sequenced plaques showed five recurrent mutations demonstrating that we are able to induce mutations with our experimental setup and that we are able to evolve enzymes (Fig. 7). | For the evolution of proteins via PREDCEL the addition of a Mutagenesis Plasmid (MP) is essential. For our cytochrome engineering approach we have chosen MP4, which induces a medium mutation rate <x-ref>badran2015development</x-ref>. After six iterations of our optimized PREDCEL workflow, we performed plaque assays and sequenced single plaques. The sequenced plaques showed five recurrent mutations demonstrating that we are able to induce mutations with our experimental setup and that we are able to evolve enzymes (Fig. 7). | ||
Line 86: | Line 86: | ||
functionality of the Accessory Plasmid and the Selection Plasmid, | functionality of the Accessory Plasmid and the Selection Plasmid, | ||
respectively. Adding theophylline increases the geneIII expression | respectively. Adding theophylline increases the geneIII expression | ||
− | 2-fold. Adding caffeine enhances the conversion of caffeine to | + | 2-fold. Adding caffeine enhances the conversion of caffeine by CYP1A2 to |
theophylline and thus increases the geneIII expression as well.| | theophylline and thus increases the geneIII expression as well.| | ||
Revision as of 03:14, 2 November 2017
Cytochrome Engineering
Directing CYP1A2 product specificity
Introduction
Enzymes, i.e. proteins mediating specific, catalytic functions, are amongst the most powerful molecular machines invented by nature. Since decades, humans utilize naturally occurring enzymes as bio detergents (e.g. in washing powderThe engineering of novel enzymes catalyzing reactions that do not or only inefficiently occur in nature holds great promise for biotechnological production of regenerative fuel, biomaterials and novel pharmaceuticals, e.g. based on Organosilicons. However, so far, enzyme engineering has typically been a time-consuming, elaborate, expensive and inefficient process, usually requiring laborious, iterative trial-and-error optimization of engineered candidates
To accelerate the development of novel enzymes, our team harnessed the engineering strategy nature uses: Evolution.